News
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor ...
The Florida Cancer Specialists & Research Institute (FCS) has introduced a liquid biopsy test to identify circulating cells ...
The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.
BY DR. AMANI JAMBHEKARCHRISTUS St. Vincent Specialists ClinicLos Alamos My name is Amani Jambhekar and I’m a breast cancer and melanoma surgeon in Santa Fe, NM. I’m also certified in Cancer ...
ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Sharon Choi discussing comprehensive genomic profiling of Black and non-Hispanic White men with prostate cancer. Racial ...
The FDA has already approved PARP inhibitors in certain patients with metastatic castration-resistant prostate cancer (mCRPC) ...
(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. April Rose discussing a ctDNA–directed phase II study of carboplatin in patients with ...
Myriad Oncology provides a portfolio of advanced genetic and tumor genomic testing solutions, including risk assessment, ...
15d
Tribune Content Agency on MSNHow is metastatic prostate cancer detected and treated in men over 70?National guidelines on prostate cancer screening with the PSA test are set by the US Preventive Services Task Force. Marc B. Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical ...
Standard medical practice is to not test men who have a life expectancy of less than 10 years for prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results